Skip to content

Evaluation of the effects of surgicel in open prostatectomy surgery

Comparison of Open Prostatectomy Patients In terms of Bleeding and Operative site Infection,with and without Surgicel

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200219046557N1
Enrollment
30
Registered
2020-03-26
Start date
2018-09-23
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open prostatectomy.

Interventions

Intervention 1: Intervention group: Surgicel (a topical cellulose homeostatic agent) will be used to control bleeding. Intervention 2: Control group:Bleeding is controlled by an electrocautery (with

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patient who are candidates for open prostatectomy Patients aged 40 to 90 years Having informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Existence of an bleeding disorder History of previous prostatic or urethral surgery; (c) Having bladder stone.

Design outcomes

Primary

MeasureTime frame
Hemoglobin level. Timepoint: Preoperative, postoperative, days 2 and 3. Method of measurement: According to the lab and on the basis grams per deciliter.;Intraoperative blood loss. Timepoint: At the end of surgery. Method of measurement: The volume of blood absorbed by surgical gauze was estimated using Gauze Visual Analogue method. The mentioned figures plus the amount of blood in the surgical suction pump was considered as the total amount of intraoperative blood loss.;Hematocrit. Timepoint: Preoperative, postoperative, days 2 and 3. Method of measurement: According to the lab and on the basis percent.

Secondary

MeasureTime frame
Infection. Timepoint: 7 days after surgery. Method of measurement: Redness,secretion, tenderness in the wound or wound dehiscence.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamed Dadashkarimi

Tabriz University of Medical Sciences

dadashkarimihamed@gmail.com0413347054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026